Towards Healthcare

News

Your Daily Gateway to Essential News in Healthcare, Science, Technology and Business Worldwide

Ansell’s new tech solution with aerofit ™ technology
22 October 2025

Ansell’s new tech solution with aerofit ™ technology

Image Credit: Ansell Announcement  Ansell Limited, a known expert in protection solutions, introduced the hyflex™ precision comfort series with the AEROFIT™ technology. It’s a new addition of industrial gloves engineered to elevate productivity and precision of workers by ...

Sanofi in millions of deal with EVOQ
22 October 2025

Sanofi in millions of deal with EVOQ

Image Credit: Business Standard Announcement  Sanofi is making headlines with another autoimmune pact by joining Chicago’s EVOQ Therapeutics for its exclusive technology that focuses on restoring the natural immune tolerance in the body. The partners are yet to reveal their primary in...

Arima Genomics’ new study shows multipurpose advantage
20 October 2025

Arima Genomics’ new study shows multipurpose advantage

Image Credit: Yahoo Finance Announcement  The Arima Genomics, Inc., a leading structure information and whole-genome sequence-focused company serving robust cancer therapy selection insights, has declared its new study led by an investigator group at Johns Hopkins University, highlighting t...

Bio-Techne and Saguaro enter a distribution agreement
20 October 2025

Bio-Techne and Saguaro enter a distribution agreement

Image Credit: Stock Titan Announcement  The Saguaro Biosciences, a leader in non-toxic live cell reagents for improved drug insights, has entered a distributive partnership agreement with Bio-Techne Corporation, a leading provider of science tools, diagnostic and reagents products. The coll...

PharmaTher's new AI platform to fuel extensive growth of ketamine portfolio
20 October 2025

PharmaTher's new AI platform to fuel extensive growth of ketamine portfolio

Image Credit: Newsfile Corp Announcement The Pharmather Holdings Ltd, a leading speciality life sciences company targeting the discovery of the pharmaceutical capability of ketamine, has introduced a new ketAlmine™. It’s a patented ketamine exploratory and redefined platform engineer...

Thermo Fisher Scientific’s microarray solution to boost multi-omics research
20 October 2025

Thermo Fisher Scientific’s microarray solution to boost multi-omics research

Image Credit: Siliconindia Announcement  Thermo Fisher Scientific, a recognised expert in delivering science, has launched the Applied Biosystems SwiftArrayStudio microarray analyser. The analyser is engineered for scalable and quick sample analysis. In connection with two new arrays, the A...

IGC Pharma extends its phase 2 CALMA clinical trial
17 October 2025

IGC Pharma extends its phase 2 CALMA clinical trial

Image Credit: Morningstar Announcement  The IGC Pharma Inc., the leading clinical-level biotechnology company accelerating AI to establish creative alternative treatments for alzheimer’s disease, have declared its extension of its running phase 2 CALMA clinical trial examining investi...

Centinel Spine received a green signal for its devices
17 October 2025

Centinel Spine received a green signal for its devices

Image Credit: Orthostreams Announcement  The Centinel Spine, LLC, the popular medical device company targeting treatment of lumbar spinal disease and cervical, with clinically proven and the completion of total disc replacement (TDR) technology platform under prodisc®, proudly confirmed...

NeoGenomics’s data presentation at the ESMO Congress 2025
17 October 2025

NeoGenomics’s data presentation at the ESMO Congress 2025

Image Credit: NeoGenomics Announcement  The neogenomics, inc the known provider of oncology diagnostic solutions that allow accuracy in medicine highlighted its presentation of assay-suitable data, involving the ongoing interventional therapy trials to put light on how its molecular residua...

Kailera Banks' financial support for the phase 3 obesity study
17 October 2025

Kailera Banks' financial support for the phase 3 obesity study

Image Credit: Yahoo Finance Announcement  Among the numerous large funding rounds this year, Kailera Therapeutics has raised $600 million in Series B proceeds to streamline weight loss therapy. The company confirmed that it will use this funding to introduce a worldwide phase 3 program for ...